Hematopoietic somatic mutations in atherosclerotic cardiovascular disease.
Blood cell mutations long associated only with aging also drive heart disease through inflammation, revealing a new biological bridge between two major diseases.
This Atherosclerosis review synthesizes evidence on how hematopoietic somatic mutations — the genetic basis of clonal hematopoiesis — drive atherosclerotic cardiovascular disease through inflammatory mechanisms. CHIP-CVD is an emerging area bridging hematology and cardiology with therapeutic implications.
What the study was
- Study design
- Narrative review — hematopoietic somatic mutation (clonal hematopoiesis) and atherosclerotic CVD
- Category
- Prevention
- Maturity
- Exploratory
- Journal
- Atherosclerosis
Why it surfaced
Clonal hematopoiesis + CVD is an important emerging field linking hematology and cardiology. Review format limits design score. Score 6/10: interesting crossover (2), relevant for cardiovascular prevention (2), review design (1), broad CVD population (1).
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.